Emerging Pharmaceutical Markets: Industry Challenges

Posted 06 August 2013 By Sofina Jain, RAC

Emerging pharmaceutical markets will account for 30% of global spending in 2016. With growing economies, big patient pools, increasing numbers of patients with chronic diseases and regulatory bodies motivated to bring new medicines to market, these countries could be the oasis that pharmaceutical giants need amid a growing desert of drugs going off-patent and increasing generic competition in mature markets like the US and Europe.

Share this article:


Regulatory Exchange: Latest Updates From the Community